To determine the incidence of secondary meningococcal infection in close family and household contacts of index patients and to review the efficacy of chemoprophylaxis the records of 3256 cases occurring from 1984 through 1987 were examined. Seventeen secondary cases (0.5%) of infection were identified among these groups. The median interval between index and secondary cases was seven weeks. Fourteen secondary cases occurred more than one week after the disease was diagnosed in the index case.
Introduction
Secondary cases of meningococcal infection occur in close contacts of an index case.' Those at greatest risk are household contacts, particularly children under the age of 5.2 Previous reports have included secondary cases occurring only within a finite period (a maximum of 60 days) after the diagnosis of the index case.23
Although the greatest risk of infection occurs in the first week after recognition of the index case,2 intervals of onset between index and secondary cases of several months have been reported recently,6 suggesting that previous studies may have underestimated rates of secondary attack.
The risk of meningococcal infection in household contacts is considered to be 500 to 800 times higher than that in the general population (4 2 secondary cases per 1000 household contacts) during a non-epidemic period.3 As rifampicin may effectively eradicate the carrier state, prophylaxis with rifampicin for household contacts of a patient with meningococcal infection has been recommended in both Britain and North America."8 Yet the efficacy of chemoprophylaxis in preventing secondary meningococcal infection remains statistically unproved.3
We examined the clinical, epidemiological, and microbiological features ofsecondary cases ofmeningococcal infection in England and Wales over a four year endemic period. Because we used sensitive typing schemes to confirm that meningococci isolated in index and secondary cases were identical we could leave the maximum time interval between such cases undefined. We examined the current incidence of secondary meningococcal infection in close family and household contacts and reviewed the efficacy of chemoprophylaxis.
The criteria used for the chemoprophylaxis of meningococcal infection have been much debated. A recent report recommended that rifampicin should remain the agent of choice and be given to all close family and household contacts within 24 hours after recognition ofthe index case.' Furthermore, rifampicin should be given to the index patient before discharge from hospital. Nasopharyngeal swabs should be taken from all close contacts one to two weeks after chemoprophylaxis to detect any failure to eradicate the infecting strain. We adopted these criteria as the basis of an optimal chemoprophylactic regimen against which the measures taken during this study could be compared.
Patients and methods
The study was 
Results
From January 1984 to December 1987, 17 secondary cases of meningococcal infection were identified. They were associated with 16 index cases, two secondary cases having occurred in one household. Apart from four secondary cases related to an outbreak in Gloucestershire6 there was no geographical clustering ofcases. Table I shows the yearly incidence ofsecondary cases. 13 children and two adults (nine male, six female). Twelve of the index children and 10 of the secondary children were aged under 7. The median age of both groups was 3. In the secondary group 11 of the children were siblings (seven brothers (one twin) and four sisters (one triplet)). The other two secondary children were a cousin and a close friend of the index patient. The two adult secondary patients were parents of index patients.
Meningococcal meningitis was diagnosed in all cases. Presenting symptoms and signs were similar in both index and secondary cases. No patient had a history of meningitis or tonsillectomy. There was one death, of a secondary patient, who died on admission. Analysis of the questionnaires on case history showed no significant difference in epidemiological features between the index and control cases (table III) . In 1984-7 the overall yearly incidence of meningococcal disease in England and Wales (population about 50 million) was 1 6/100000 inhabitants. The median number of household members in the control case group during these four years was four. Hence an estimated 9717 people were exposed to 3239 primary cases. The 17 secondary cases, which all occurred within nine months of their index cases, represent a yearly rate of secondary attack of 2-3/1000 household members, a relative risk of 144 compared with the general population.
Discussion
Despite chemoprophylaxis the incidence of secondary cases documented in this survey was high, particularly as not all cases are reported. A direct comparison with estimates in previous studies, in which no chemoprophylaxis was given, would be invalid as the definitions of a secondary case were different. One of our most striking findings was the extended interval between illness in the index and some secondary cases. The median interval of seven weeks falls beyond the limit set in some studies.35 The prolonged period over which family contacts are at risk clearly implies either that the initial preventive measures are failing to eradicate the infecting strain from the family or that the strain is being reintroduced from a carrier outside the family group.
Three factors may have accounted for the failure of preventive measures: the nature of the family, the extent of the prophylaxis given, and the infecting strain. By In one of the secondary cases the patient, who had received two courses of rifampicin after the notification of the index case, was infected with a variant of the index strain that was resistant to rifampicin. Resistance to rifampicin among meningococcal isolates associated with septicaemia or meningitis received by the Manchester meningococcal reference laboratory remains extremely low. Meningococcal disease caused by a rifampicin resistant organism in a contact who had received rifampicin prophylaxis has been reported previously.2 The current case was unusual in that the strain was also fairly insensitive to penicillin (minimum inhibitory concentration 0-8 mg/l). The other case of interest was one in which the patient developed meningitis due to a meningococcus sensitive to rifampicin while receiving rifampicin.
When assessing the adequacy of the chemoprophylactic measures used, establishing precise details about variables such as compliance is clearly extremely difficult in a retrospective study. In one family, however, there was a complete failure to give prophylaxis, probably because of poor communication. Rifampicin was used as the prophylactic agent in all the other families and was prescribed for all the family members as recommended, though poor compliance was documented in one family. In 13 families, however, other possible shortcomings were identified. In eight cases the index patient was not given rifampicin before discharge and so may have reintroduced the strain to the family. In eight families prophylaxis was not given within 24 hours after admission of the index patient, though if the dates of onset in the secondary cases are considered the fairly short delay (less than three days in all cases) was probably not important. Because of the uncertainties about the ability of rifampicin to eradicate meningococcal carriage among a family group'3 follow up swabs should be obtained about one week after prophylaxis to try to identify failures. This measure, which admittedly is rather insensitive, was performed in only two of the families in which secondary cases occurred.
The distribution of serogroups of the meningococci isolated in the secondary cases (table II) was different from that in the control case group, which in turn matched that in the general population (A 4%, B 59%, C 35%). Although this difference was not significant, possibly the underrepresentation of group C strains was a function of the impact of chemoprophylaxis on the higher rates of carriage and transmissibility associated with group C infection compared with the more prolonged and lower rates of carriage seen with group B disease. 6 Our results suggest that some of the secondary cases identified could have been prevented by a more rigorous adherence to the recommendations for chemoprophylaxis, including giving prophylaxis to the index patient before discharge and adopting swabbing after prophylaxis. We also conclude, however, that with the currently available prophylactic agents, even when administered in what is regarded as the optimal manner, the risk of infection in family contacts remains. This emphasises the need to combine chemoprophylaxis with clinical surveillance of the family group and to keep the possibility of meningitis in mind when non-specific febrile illnesses occur in the family, even months after the illness of the index patient. 
Abstract
Objective-To determine the incidence of insulin dependent diabetes mellitus up to the age of 21 in a geographicaily defined population in England with independent validation of completeness of case ascertainment.
Design-Prospective registration of newly diagnosed cases supplemented by centralised hospital discharge records and death certificates. Validation of ascertainment from general practitioners.
Setting-Oxford Regional Health Authority area (population 2-4 million).
Patients-All patients with insulin dependent diabetes diagnosed below age 21 during 1985-6 and resident in the region at the time of diagnosis.
Interventions-None. End point-Validation of a method of case ascertainment for assessing temporal variation in incidence of insulin dependent diabetes.
Measurements and main results-The overall yearly incidence of newly diagnosed insulin dependent diabetes mellitus in people under 21 was cases/100 000 (95% confidence interval 13.6 to 17-6).
Among males the incidence was 16-8 cases (14-0 to 19.7)/100 000 and among females 14-3 cases (11-6 to 17.1)/100000. The highest incidence, in the 10-14 year age group, was 26-4 (20-9 to 31-8) new cases/ 100000 population yearly. Case ascertainment was greater than 95%.
Conclusions-The incidence of insulin dependent diabetes in England is considerably higher than reported from large scale studies. It is consistent with described patterns of geographical variation. The figures provide a baseline for assessing temporal change.
Introduction
Despite the fact that insulin dependent diabetes mellitus is one of the commonest chronic illnesses of childhood and still carries considerable morbidity and mortality, little epidemiological information is available on its occurrence in England. There are, for example, no large scale studies with case ascertainment complete enough to permit comparisons with other countries in respect of overall incidence or the characteristics of patients developing the disease. Similar comparisons have shown pronounced geographical variation-for example, a child in Finland is 17 times more likely to develop insulin dependent diabetes than one in Hokkaido, Japan'-and seem likely to contribute important insights into the aetiology of the disease. Our aim was to derive accurate incidence rates for insulin dependent diabetes in a geographically defined population in England, by using independent Recent reports suggest that there has been a rapid increase in the incidence of insulin dependent diabetes over the past 20 to 30 years. This survey was therefore planned as a baseline for assessing the temporal variation in England. Such a study requires case ascertainment methods that will remain accurate and appropriate for the foreseeable future. We have therefore investigated the current management of new cases of insulin dependent diabetes, in particular the recent trend towards outpatient care, in assessing possible methods of ascertainment.
Patients and methods
The study formed part of the Barts-Oxford study of childhood diabetes, which covers the Oxford Regional Health Authority area (figure). This is divided into eight health districts, each containing one or more general hospitals. The area is 3130 square miles (8107 km2) and has a population of 2-4 million, including 750 000 under the age of 21. Six per cent of the population under 15 is thought to be non-Europid, mainly originating from the Indian subcontinent. The Barts-Oxford study is being undertaken in col-
